Learn from our biopharma experts, explore stimulating thought leadership and see some of our clients’ past successes.
White Paper – CAR-T: Advancing the Path for Clinical and Commercial Success
The Prescient team has prepared a white paper discussing our view on the recent advances in the CAR-T landscape. Industry and academia appear to be making significant strides in simplifying manufacturing and administration processes, expanding clinical utility and enabling access for patients.
By: Ben Doran, Stuart Crichton, Ben Druck and Vasiliki Patsioura
Click below and complete the form to receive the white paper via email.